Rapid Treatment Initiation in HIV

Opinion
Video

Focusing on the importance of rapid treatment initiation in HIV, Shauna Applin, ARNP, reviews available therapies and provides clinical insights on treatment considerations.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      BIC = bictegravir

      DRV = darunavir

      DTG = dolutegravir

      F/TAF = FTC/TAF = Emtricitabine/Tenofovir alafenamide

      F/TDF = FTC/TDF = Emtricitabine/Tenofovir disoproxil fumarate

      B/F/TAF = BIC/FTC/TAF = Bictegravir/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

      DTG/ABC/3TC = Dolutegravir/Abacavir/Lamivudine (single tablet regimen)

      DTG + F/TAF = DTG + FTC/TAF = Dolutegravir + Emtricitabine/Tenofovir alafenamide (multi-tablet regimen)

      D/C/F/TAF = DRV/COBI/FTC/TAF = Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

      DTG/3TC = Dolutegravir/Lamivudine (single tablet regimen)

      CAB = Cabotegravir

      CAB + RPV = Cabotegravir + Rilpivirine

      Video content above is prompted by the following questions:

      • Perspectives on the rate of treatment initiation for newly diagnosed HIV have shifted over the years, leading to consensus on the importance of initiating treatment quickly.
        • Can you expand on the importance of a rapid start?
        • What are the guideline-recommended therapies for a rapid start?
        • What are the differences between them?
      Recent Videos
      The Importance to Address and Help Visceral Adiposity in HIV Patients
      The Importance to Address and Help Visceral Adiposity in HIV Patients
      Clinical Insights on HIV-Associated Visceral Fat Following FDA Approval of Tesamorelin F8
      Clinical Insights on HIV-Associated Visceral Fat Following FDA Approval of Tesamorelin F8
      Phase II Study Shows Efficacy of 6-Month Regimen of Lenacapavir, Teropavimab, and Zinlirvimab for HIV
      Phase II Study Shows Efficacy of 6-Month Regimen of Lenacapavir, Teropavimab, and Zinlirvimab for HIV
      ALLIANCE Study: B/F/TAF Achieves Sustained HIV and HBV Suppression
      ALLIANCE Study: B/F/TAF Achieves Sustained HIV and HBV Suppression
      Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial
      Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial
      ViiV Healthcare Presents Potential Long-Acting HIV Therapies
      ViiV Healthcare Presents Potential Long-Acting HIV Therapies
      The Business Sector's Advocacy to Maintain Funding for HIV Prevention, Research, Treatment
      The Business Sector's Advocacy to Maintain Funding for HIV Prevention, Research, Treatment
      Apretude PrEP Shows High Efficacy, Safety in Diverse Studies
      Apretude PrEP Shows High Efficacy, Safety in Diverse Studies
      HIV Prevention: Discussing PrEP, PEP, and Vaccine Development
      HIV Prevention: Discussing PrEP, PEP, and Vaccine Development
      The FRESH Study Tests New HIV Remission Strategy in South African Women
      The FRESH Study Tests New HIV Remission Strategy in South African Women
      Related Content
      FDA Approves F8 Formulation of Theratechnologies' Tesamorelin for HIV-Associated Lipodystrophy

      FDA Approves F8 Formulation of Theratechnologies' Tesamorelin for HIV-Associated Lipodystrophy

      Sophia Abene;Christian Marsolais, PhD
      March 25th 2025
      Article
      "A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People

      "A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People

      Nina Cosdon
      June 10th 2022
      Podcast
      First-in-Human Study of Long-Acting Injectable HIV Nanoparticle Combination Therapy

      First-in-Human Study of Long-Acting Injectable HIV Nanoparticle Combination Therapy

      Sophia Abene
      March 19th 2025
      Article
      “We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

      “We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

      Nina Cosdon
      March 18th 2022
      Podcast
      Pandemic Disruptions in HIV Care Impacted on Early ART Initiation and Viral Suppression

      Pandemic Disruptions in HIV Care Impacted on Early ART Initiation and Viral Suppression

      Sophia Abene
      March 13th 2025
      Article
      Exploring Novel Dosing Strategies by Reducing Once Daily Biktarvy

      Exploring Novel Dosing Strategies by Reducing Once Daily Biktarvy

      John Parkinson
      March 11th 2025
      Article
      © 2025 MJH Life Sciences

      All rights reserved.